You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR FLORTAUCIPIR F-18

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for FLORTAUCIPIR F-18

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT01992380 ↗	A Study of Flortaucipir PET in Healthy Volunteers and Cognitively Impaired Subjects	Completed	Avid Radiopharmaceuticals	Phase 1	2013-11-13	This study will test if two flortaucipir PET scans up to 4 weeks apart in healthy volunteers, MCI and AD subjects provide the same results.
NCT02016560 ↗	Analysis of 18F-AV-1451 PET Imaging in Cognitively Healthy, MCI, and AD Subjects	Completed	Avid Radiopharmaceuticals	Phase 2/Phase 3	2013-12-01	A Phase 2/3 cross-sectional and longitudinal observational study evaluating imaging characteristics of flortaucipir in control subjects and patients with clinically defined MCI and AD dementia (AD).
NCT02051764 ↗	Imaging Characteristics of a Follow-up 18F-AV-1451 Scan	Terminated	Avid Radiopharmaceuticals	Phase 2	2014-05-01	This study will evaluate the imaging characteristics of flortaucipir in subjects with a previous flortaucipir scan in order to assess the rate of change of tau deposition over time.
NCT02079766 ↗	18F-AV-1451 and Florbetapir F 18 PET (Positron Emission Tomography) Imaging in Subjects at Risk for Chronic Traumatic Encephalopathy	Completed	Avid Radiopharmaceuticals	Phase 2	2014-06-01	This study will explore the use of flortaucipir as a biomarker for chronic traumatic encephalopathy (CTE) and examine the relationship between clinical presentation and tau deposition.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for FLORTAUCIPIR F-18

Condition Name

Chart
Table

Condition Name for FLORTAUCIPIR F-18
Intervention	Trials
Alzheimer's Disease	9
Alzheimer Disease	8
Cognitive Decline	2
Progressive Supranuclear Palsy	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for FLORTAUCIPIR F-18
Intervention	Trials
Alzheimer Disease	17
Dementia	3
Cognitive Dysfunction	3
Brain Injuries, Traumatic	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for FLORTAUCIPIR F-18

Trials by Country

Map
Table

Trials by Country for FLORTAUCIPIR F-18
Location	Trials
United States	76
Australia	3
Canada	2
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for FLORTAUCIPIR F-18
Location	Trials
California	11
Pennsylvania	8
Massachusetts	6
Texas	5
Rhode Island	5
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for FLORTAUCIPIR F-18

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for FLORTAUCIPIR F-18
Clinical Trial Phase	Trials
Phase 3	3
Phase 2/Phase 3	1
Phase 2	8
[disabled in preview]	8
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for FLORTAUCIPIR F-18
Clinical Trial Phase	Trials
Completed	16
Terminated	2
Not yet recruiting	2
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for FLORTAUCIPIR F-18

Sponsor Name

Chart
Table

Sponsor Name for FLORTAUCIPIR F-18
Sponsor	Trials
Avid Radiopharmaceuticals	18
National Institute on Aging (NIA)	1
Tharick Pascoal	1
[disabled in preview]	1
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for FLORTAUCIPIR F-18
Sponsor	Trials
Industry	19
Other	4
NIH	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.